Professor Colin Baigent
Professor of Epidemiology, Clinical Trial Service Unit
Professor Baigent researches cardiovascular epidemiology. He works on the design, conduct and application of large-scale randomised trials in cardiovascular disease. His research has helped determine the effects of aspirin, non-steroidal anti-inflammatory drugs (such as ibuprofen and naproxen), fibrinolytic therapy, and statins in different types of patients. His group has also contributed to a better understanding of cardiovascular disease in patients with renal impairment through the Study of Heart and Renal Protection (SHARP), the largest ever in patients with moderate-to-severe chronic kidney disease.
- Kidney disease
- Non-steroidal anti-inflammatory drugs
- Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials (2015)
- Neprilysin inhibition in chronic kidney disease (2015)
- What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease? (2015)
Professor Baigent has extensive media experience in radio and TV, both live and pre-recorded, and in print and online media.